Phathom Pharmaceuticals
PHAT
PHAT
94 hedge funds and large institutions have $334M invested in Phathom Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 23 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
6% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 18
0% more funds holding
Funds holding: 94 → 94 (0)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
94
Holding in Top 10
3
Calls
$1.92M
Puts
$3K
Top Buyers
| 1 | +$28.6M | |
| 2 | +$26.8M | |
| 3 | +$2.48M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$1.24M |
| 5 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$1.1M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$9.22M | |
| 3 | -$6.7M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$2.84M |
| 5 |
WSL
Western Standard LLC
Los Angeles,
California
|
-$920K |